From injecting lab-made substances similar to immune cells to modifying the body’s soldier T-cells, immunotherapy has a lot of potential in treating cancer even when other therapies fail.Immunotherapy is delivered alongside other treatments, such as chemotherapy and radiation therapy, many times. ...
This article presents global cancer statistics by world region for the year 2022 based on updated estimates from the International Agency for Research on Cancer (IARC). There were close to 20 million...
Of the BRIC countries, the market for breast cancer treatments is currently largest in Brazil (with about 50% of the total market share), but it is thought that China will experience the largest growth over the next 5years. Across all four countries, trastuzumab [ Herceptin ] is the ...
With the advent of direct acting antivirals (DAAs) the World Health Organisation (WHO) adopted global strategy to eliminate hepatitis C virus (HCV) infection by 2030. In Europe, people who inject drugs (PWID) account for the majority of new cases, howeve
Quantitative Imaging for Evaluation of Response to Cancer Therapy Advances in molecular medicine offer the potential to move cancer therapy beyond traditional cytotoxic treatments to safer and more effective targeted therapies based on molecular characteristics of a patient's tumor. Within this context......
By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection. See our privacy policy for more information on the use of your perso...
COVID-19 has become one of the few leading causes of death and has evolved into a pandemic that disrupts everyone’s routine, and balanced way of life
doi:10.1001/jamaoncol.2020.7478 editorial comment icon Editorial Comment Editorial Aligning Cancer Clinical Trials With Cancer Burden Aakash Desai, MBBS, MPH; Nicole M. Kuderer, MD; Gary H. Lyman, MD, MPH JAMA Oncology Key Points Question To what extent do oncology randomized clinical trials (RCT...
In recent decades, variability in the incidence and mortality of kidney cancer (KC) has been reported. This study aimed to compare trends in incidence, mortality, and disability-adjusted life years (DALY) of KC between the European Union (EU) 15 + countries and 6 World Health Organization...
Although not every patient will require them, chemotherapy and radiotherapy are key treatment options—it's estimated around 4 in 10 people with cancer in the UK should receive radiotherapy as part of their care. With cancer cases projected to rise in the UK, demand for these treatments will s...